MX2021015256A - Mezcla de extractos vegetales para el uso en la prevención y/o tratamiento de enfermedades intestinales inflamatorias crónicas. - Google Patents
Mezcla de extractos vegetales para el uso en la prevención y/o tratamiento de enfermedades intestinales inflamatorias crónicas.Info
- Publication number
- MX2021015256A MX2021015256A MX2021015256A MX2021015256A MX2021015256A MX 2021015256 A MX2021015256 A MX 2021015256A MX 2021015256 A MX2021015256 A MX 2021015256A MX 2021015256 A MX2021015256 A MX 2021015256A MX 2021015256 A MX2021015256 A MX 2021015256A
- Authority
- MX
- Mexico
- Prior art keywords
- prevention
- treatment
- extract
- inflammatory bowel
- chronic inflammatory
- Prior art date
Links
- 208000022559 Inflammatory bowel disease Diseases 0.000 title abstract 2
- 230000001684 chronic effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 239000000419 plant extract Substances 0.000 title 1
- 241000196324 Embryophyta Species 0.000 abstract 2
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 abstract 2
- 229940075559 piperine Drugs 0.000 abstract 2
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 abstract 2
- 235000019100 piperine Nutrition 0.000 abstract 2
- 239000007858 starting material Substances 0.000 abstract 2
- RFWGABANNQMHMZ-UHFFFAOYSA-N 8-acetoxy-7-acetyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline Natural products CC=C1C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O RFWGABANNQMHMZ-UHFFFAOYSA-N 0.000 abstract 1
- 241000020085 Chrysanthellum Species 0.000 abstract 1
- 244000019459 Cynara cardunculus Species 0.000 abstract 1
- 235000019106 Cynara scolymus Nutrition 0.000 abstract 1
- HKVGJQVJNQRJPO-UHFFFAOYSA-N Demethyloleuropein Natural products O1C=C(C(O)=O)C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(=CC)C1OC1OC(CO)C(O)C(O)C1O HKVGJQVJNQRJPO-UHFFFAOYSA-N 0.000 abstract 1
- 241000282414 Homo sapiens Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- RFWGABANNQMHMZ-HYYSZPHDSA-N Oleuropein Chemical compound O([C@@H]1OC=C([C@H](C1=CC)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-HYYSZPHDSA-N 0.000 abstract 1
- 241000987614 Royena glabra Species 0.000 abstract 1
- 235000016520 artichoke thistle Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- RFWGABANNQMHMZ-CARRXEGNSA-N oleuropein Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C(=CC)[C@H]1CC(=O)OCCc3ccc(O)c(O)c3 RFWGABANNQMHMZ-CARRXEGNSA-N 0.000 abstract 1
- 235000011576 oleuropein Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se refiere a una composición que comprende al menos: - un extracto de Chrysanthellum, y - un extracto de alcachofa, y - un extracto de arándano, y - un extracto de al menos una materia prima de origen vegetal que comprende oleuropeína, - y opcionalmente piperina sintética y/o un extracto de al menos una materia prima de origen vegetal que comprende piperina, para el uso como un producto farmacéutico o nutricional en la prevención y/o el tratamiento de la enfermedad intestinal inflamatoria crónica en humanos o animales.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1906165A FR3097122B1 (fr) | 2019-06-11 | 2019-06-11 | Melange d’extraits de plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l’intestin |
| PCT/EP2020/066164 WO2020249657A1 (fr) | 2019-06-11 | 2020-06-11 | Melange d'extraits de plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l'intestin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021015256A true MX2021015256A (es) | 2022-04-12 |
Family
ID=67441498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021015256A MX2021015256A (es) | 2019-06-11 | 2020-06-11 | Mezcla de extractos vegetales para el uso en la prevención y/o tratamiento de enfermedades intestinales inflamatorias crónicas. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20220257685A1 (es) |
| EP (1) | EP3982924B1 (es) |
| JP (1) | JP2022535964A (es) |
| KR (1) | KR20220027950A (es) |
| CN (1) | CN114502141A (es) |
| AU (1) | AU2020292586A1 (es) |
| BR (1) | BR112021025056A2 (es) |
| CA (1) | CA3142860A1 (es) |
| CL (1) | CL2021003291A1 (es) |
| DK (1) | DK3982924T3 (es) |
| ES (1) | ES2963639T3 (es) |
| FI (1) | FI3982924T3 (es) |
| FR (1) | FR3097122B1 (es) |
| HR (1) | HRP20231360T1 (es) |
| HU (1) | HUE064209T2 (es) |
| IL (1) | IL288882A (es) |
| MX (1) | MX2021015256A (es) |
| PL (1) | PL3982924T3 (es) |
| PT (1) | PT3982924T (es) |
| SI (1) | SI3982924T1 (es) |
| WO (1) | WO2020249657A1 (es) |
| ZA (1) | ZA202110225B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202100002735A1 (it) * | 2021-02-08 | 2022-08-08 | Phytoitalia Srl | Metodo di estrazione e arricchimento di flavonoidi monoglicosilati da chrysanthellum indicum per il trattamento di patologie poliartritiche su base infiammatoria, per l'uso in dispositivi cosmetici, nutraceutici, medici e applicazioni farmaceutiche |
| CN115120604A (zh) * | 2021-03-24 | 2022-09-30 | 陕西凤丹正元生物科技有限公司 | 芹菜素7-o-葡萄糖苷作为降尿酸和痛风性关节炎制剂的应用 |
| CN114903910A (zh) * | 2022-05-09 | 2022-08-16 | 淮阴师范学院 | 芹菜素-7-O-β-D-葡萄糖苷在制备炎症性肠病治疗药物中的应用 |
| CN115645429B (zh) * | 2022-12-12 | 2023-05-16 | 汤臣倍健股份有限公司 | 一种花色苷组合物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013070898A1 (en) * | 2011-11-09 | 2013-05-16 | Master Holdings Llc | Extracts |
| FR3027228B1 (fr) * | 2014-10-20 | 2016-12-09 | Valbiotis | Composition comprenant un melange d'extraits vegetaux et utilisation pour agir sur le metabolisme glucidique et/ou lipidique |
| WO2016156527A1 (fr) * | 2015-03-31 | 2016-10-06 | International Nutrition Research Company | Composition pour le traitement d'un etat metabolique pathogene du microbiote intestinal et des maladies derivees |
| FR3042411B1 (fr) * | 2015-10-20 | 2019-07-12 | Valbiotis | Composition comprenant un melange de molecules particulieres et utilisation pour agir sur le metabolisme glucidique et/ou lipidique |
-
2019
- 2019-06-11 FR FR1906165A patent/FR3097122B1/fr active Active
-
2020
- 2020-06-11 SI SI202030302T patent/SI3982924T1/sl unknown
- 2020-06-11 JP JP2021573481A patent/JP2022535964A/ja active Pending
- 2020-06-11 AU AU2020292586A patent/AU2020292586A1/en active Pending
- 2020-06-11 FI FIEP20734655.2T patent/FI3982924T3/en active
- 2020-06-11 KR KR1020227000895A patent/KR20220027950A/ko unknown
- 2020-06-11 CN CN202080045209.3A patent/CN114502141A/zh active Pending
- 2020-06-11 MX MX2021015256A patent/MX2021015256A/es unknown
- 2020-06-11 CA CA3142860A patent/CA3142860A1/fr active Pending
- 2020-06-11 BR BR112021025056A patent/BR112021025056A2/pt not_active Application Discontinuation
- 2020-06-11 HU HUE20734655A patent/HUE064209T2/hu unknown
- 2020-06-11 HR HRP20231360TT patent/HRP20231360T1/hr unknown
- 2020-06-11 US US17/618,013 patent/US20220257685A1/en active Pending
- 2020-06-11 DK DK20734655.2T patent/DK3982924T3/da active
- 2020-06-11 ES ES20734655T patent/ES2963639T3/es active Active
- 2020-06-11 PL PL20734655.2T patent/PL3982924T3/pl unknown
- 2020-06-11 WO PCT/EP2020/066164 patent/WO2020249657A1/fr active Application Filing
- 2020-06-11 EP EP20734655.2A patent/EP3982924B1/fr active Active
- 2020-06-11 PT PT207346552T patent/PT3982924T/pt unknown
-
2021
- 2021-12-09 IL IL288882A patent/IL288882A/en unknown
- 2021-12-09 ZA ZA2021/10225A patent/ZA202110225B/en unknown
- 2021-12-10 CL CL2021003291A patent/CL2021003291A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220027950A (ko) | 2022-03-08 |
| PL3982924T3 (pl) | 2023-12-27 |
| DK3982924T3 (da) | 2023-10-30 |
| HUE064209T2 (hu) | 2024-03-28 |
| SI3982924T1 (sl) | 2023-12-29 |
| HRP20231360T1 (hr) | 2024-02-16 |
| IL288882A (en) | 2022-02-01 |
| CL2021003291A1 (es) | 2023-02-03 |
| PT3982924T (pt) | 2023-11-29 |
| CN114502141A (zh) | 2022-05-13 |
| FR3097122B1 (fr) | 2021-06-18 |
| ES2963639T3 (es) | 2024-04-01 |
| BR112021025056A2 (pt) | 2022-02-22 |
| FI3982924T3 (en) | 2023-11-02 |
| EP3982924B1 (fr) | 2023-07-26 |
| US20220257685A1 (en) | 2022-08-18 |
| JP2022535964A (ja) | 2022-08-10 |
| ZA202110225B (en) | 2022-07-27 |
| CA3142860A1 (fr) | 2020-12-17 |
| WO2020249657A1 (fr) | 2020-12-17 |
| FR3097122A1 (fr) | 2020-12-18 |
| AU2020292586A1 (en) | 2022-01-20 |
| EP3982924A1 (fr) | 2022-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021015256A (es) | Mezcla de extractos vegetales para el uso en la prevención y/o tratamiento de enfermedades intestinales inflamatorias crónicas. | |
| PH12020500500A1 (en) | Pyrazolopyrimidinone compounds and uses thereof | |
| MX2020001513A (es) | Agentes de union a clec9a y su uso. | |
| PH12019502058A1 (en) | Farnesoid x receptor agonists and uses thereof | |
| GEP20207158B (en) | Amide-substituted pyridinyltriazole derivatives and uses thereof | |
| MX2021010868A (es) | Bacteria de la familia christensenellaceaeas en la prevencion y/o tratamiento de enfermedades inflamatorias cronicas y/o enfermedades gastrointestinales inflamatorias y/o canceres. | |
| EA201791428A1 (ru) | Иммуномодуляция | |
| PH12021550605A1 (en) | Farnesoid x receptor agonists and uses thereof | |
| PH12018500315A1 (en) | Fumagillol heterocyclic compounds and methods of making and using same | |
| CR20220215A (es) | Heteroaril bifenil amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1 | |
| EP4272832A3 (en) | Antimicrobial compounds, compositions, and uses thereof | |
| MX2018008793A (es) | Combinacion farmaceutica o nutricional que comprende beta-hidroxi-betametilbutirato. | |
| PH12019502241A1 (en) | Berberine alkaloids in the prevention and/or treatments of intestinal disease | |
| MY194024A (en) | Use of cistanche tubulosa extract and isoacteoside in protection of muscles | |
| MX2018008640A (es) | Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano. | |
| MX2021002787A (es) | Composiciones de alimento animal y usos de las mismas. | |
| PH12017500743A1 (en) | Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency | |
| PH12016501205B1 (en) | Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency | |
| PH12019501820A1 (en) | Pharmaceutical compositions for combination therapy | |
| WO2016072692A3 (ko) | 네크록스를 유효성분으로 함유하는 점막염 예방 또는 치료용 조성물 | |
| GB2550750A (en) | Anthelmintic compounds | |
| GB202017123D0 (en) | Non-toxic furocoumarin-rich plant extracts and related compositions for use as antimicrobial substances or medicament and other therapeutic uses. | |
| PH12020500120A1 (en) | Pharmaceutical compositions | |
| PH12017501949A1 (en) | Amyloid � fibril decomposing agent, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by amyloid � fibril formation | |
| MD3319586T2 (ro) | Formulări farmaceutice pentru tratamentul afecțiunilor inflamatorii ale rectului |